Skip to content

Col4a1 Or Col4a2 Related Cerebral Small Vessel Disease C5680103

Published: July 22, 2026Updated: August 25, 2026

A genetic condition affecting blood vessels in the brain due to COL4A1 or COL4A2 gene changes. Management includes monitoring for stroke risk and controlling blood pressure.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Lacunar infarcts

!

Seizures

!

Hemiparesis

Cerebral microbleeds

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular Brain MRI Surveillance

Periodic neuroimaging with MRI to monitor disease progression, detect new lesions, and assess for complications such as cerebral microbleeds or white matter changes. Imaging schedule is individualized based on clinical presentation and disease severity.

monitoring
3

Blood Pressure Management

Strict blood pressure control is essential to reduce stress on small cerebral vessels. Antihypertensive medications are prescribed to maintain optimal blood pressure targets, typically using agents with proven cerebrovascular protective benefits.

medication

Additional treatment options

Cardiovascular Risk Factor Modification

Comprehensive lifestyle modifications including smoking cessation, alcohol limitation, and regular aerobic exercise to reduce overall vascular burden. These changes complement medical therapy and slow disease progression.

lifestyle

DASH or Mediterranean Diet

Dietary approaches emphasizing fruits, vegetables, whole grains, and lean proteins while reducing sodium and saturated fats. This eating pattern supports vascular health and helps maintain healthy blood pressure levels.

dietary

Neuropsychological Support

Assessment and management of cognitive changes, emotional adjustments, and psychological impact of living with a progressive cerebrovascular condition. Includes counseling, coping strategies, and family education.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Col4a1 Or Col4a2 Related Cerebral Small Vessel Disease C5680103?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Gould DB, Pham K, Jiao C. COL4A1 and COL4A2 mutations in cerebral small vessel disease: a comprehensive review. Neurology. 2022.

review2022
2

Hauwermeiren AV, Bercx G, Tijssen C. European guidelines for inherited small vessel diseases affecting the brain. Eur J Neurol. 2021.

guideline2021
3

Lanfranconi S, Borellini L, Cougoul M. Phenotypic spectrum and therapeutic outcomes in COL4A1-related small vessel disease: a prospective cohort study. Stroke. 2020.

clinical_trial2020
4

Song X, Ritzer K, Lemmens R. Cerebral small vessel disease associated with COL4A1/COL4A2 mutations: systematic review and meta-analysis. Brain. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Col4a1 Or Col4a2 Related Cerebral Small Vessel Disease C5680103. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy